125 related articles for article (PubMed ID: 9352740)
1. Serum levels of G-CSF, IL-3, IL-6 and GM-CSF after a single intraperitoneal dose of rhG-CSF in lethally irradiated B6D2F1 mice.
Kádár E; Sureda A; Mangues MA; Inglés-Esteve J; Valls A; García J
Acta Haematol; 1997; 98(3):119-24. PubMed ID: 9352740
[TBL] [Abstract][Full Text] [Related]
2. Cytokine profile during high-dose rhG-CSF therapy in severe congenital neutropenia.
Shitara T; Yugami S; Ijima H; Sotomatu M; Kuroume T
Am J Hematol; 1994 Jan; 45(1):58-62. PubMed ID: 7504401
[TBL] [Abstract][Full Text] [Related]
3. alpha-Galactosylceramide (AGL-517) treatment protects mice from lethal irradiation.
Inoue H; Koezuka Y; Nishi N; Osawa M; Motoki K; Kobayashi E; Kabaya K; Obuchi M; Fukushima H; Mori KJ
Exp Hematol; 1997 Aug; 25(9):935-44. PubMed ID: 9257806
[TBL] [Abstract][Full Text] [Related]
4. A synergistic increase in transplantable peripheral blood stem cells in mice by co-administration of recombinant human interleukin 6 and recombinant human granulocyte colony-stimulating factor.
Suzuki H; Okano A; Suzuki C; Konishi A; Akiyama Y; Ishibashi T; Ozawa K; Asano S
Transplantation; 1995 Jun; 59(11):1596-600. PubMed ID: 7539959
[TBL] [Abstract][Full Text] [Related]
5. In vivo radioprotective effects of recombinant human granulocyte colony-stimulating factor in lethally irradiated mice.
Uckun FM; Souza L; Waddick KG; Wick M; Song CW
Blood; 1990 Feb; 75(3):638-45. PubMed ID: 1688721
[TBL] [Abstract][Full Text] [Related]
6. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
Iguchi K; Inoue S; Kumar A
Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic study of a novel recombinant human granulocyte colony-stimulating factor in rats.
Liu XX; Jiang YP
Chin Med Sci J; 2010 Mar; 25(1):13-9. PubMed ID: 20449948
[TBL] [Abstract][Full Text] [Related]
8. Granulocyte colony-stimulating factor administered as a single intraperitoneal injection modifies the lethal dose95/30 in irradiated B6D2F1 mice.
Sureda A; Kádár E; Valls A; García-López J
Haematologica; 1998 Sep; 83(9):863-4. PubMed ID: 9825589
[TBL] [Abstract][Full Text] [Related]
9. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor in the rat. Single and multiple dosing studies.
Tanaka H; Kaneko T
Drug Metab Dispos; 1991; 19(1):200-4. PubMed ID: 1708329
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of serum granulocyte-colony stimulating factor (G-CSF) concentration and G-CSF receptor expression during G-CSF treatment of cyclophosphamide-treated mice.
Matsuzaki G; Li XY; Ohyama Y; Nomoto K
Int J Immunopharmacol; 1996; 18(6-7):363-9. PubMed ID: 9024937
[TBL] [Abstract][Full Text] [Related]
12. Effect of in vivo administration of IL-3 and IL-6, alone and in combination with G-CSF, GM-CSF or IL-1, on haematopoiesis, graft-versus-host disease and survival after murine haematopoietic stem cell transplantation.
Atkinson K; Vos B; Kang-Er Z; Guiffre A; Seymour R; Gillis S
Cytokines Mol Ther; 1995 Mar; 1(1):47-55. PubMed ID: 9384663
[TBL] [Abstract][Full Text] [Related]
13. Autologous stem cell transplantation: sequential production of hematopoietic cytokines underlying granulocyte recovery.
Baiocchi G; Scambia G; Benedetti P; Menichella G; Testa U; Pierelli L; Martucci R; Foddai ML; Bizzi B; Mancuso S
Cancer Res; 1993 Mar; 53(6):1297-303. PubMed ID: 7680283
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor studied in the rat by a sandwich enzyme-linked immunosorbent assay.
Tanaka H; Tokiwa T
J Pharmacol Exp Ther; 1990 Nov; 255(2):724-9. PubMed ID: 1700818
[TBL] [Abstract][Full Text] [Related]
15. Antagonistic effects of interleukin 6 and G-CSF in the later stage of human granulopoiesis in vitro.
Katayama K; Koizumi S; Ueno Y; Ohno I; Ichihara T; Horita S; Miyawaki T; Taniguchi N
Exp Hematol; 1990 Jun; 18(5):390-4. PubMed ID: 1692536
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of the in vivo radioprotective effects of recombinant granulocyte colony-stimulating factor (G-CSF), recombinant granulocyte-macrophage CSF, and their combination.
Waddick KG; Song CW; Souza L; Uckun FM
Blood; 1991 Jun; 77(11):2364-71. PubMed ID: 1710151
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of recombinant human granulocyte colony-stimulating factor conjugated to polyethylene glycol in rats.
Tanaka H; Satake-Ishikawa R; Ishikawa M; Matsuki S; Asano K
Cancer Res; 1991 Jul; 51(14):3710-4. PubMed ID: 1712246
[TBL] [Abstract][Full Text] [Related]
18. Acceleration of hemopoietic recovery in dogs after extended-field partial-body irradiation by treatment with colony-stimulating factors: rhG-CSF and rhGM-CSF.
Nothdurft W; Kreja L; Selig C
Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1145-54. PubMed ID: 9169825
[TBL] [Abstract][Full Text] [Related]
19. Interdependence of the radioprotective effects of human recombinant interleukin 1 alpha, tumor necrosis factor alpha, granulocyte colony-stimulating factor, and murine recombinant granulocyte-macrophage colony-stimulating factor.
Neta R; Oppenheim JJ; Douches SD
J Immunol; 1988 Jan; 140(1):108-11. PubMed ID: 2447166
[TBL] [Abstract][Full Text] [Related]
20. Effects of combined administration of interleukin-6 and granulocyte colony-stimulating factor on recovery from radiation-induced hemopoietic aplasia.
Patchen ML; Fischer R; MacVittie TJ
Exp Hematol; 1993 Feb; 21(2):338-44. PubMed ID: 7678816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
